CV8 THE COST-EFFECTIVENESS (COST-UTILITY) OF EPROSARTAN IN HYPERTENSIVE PATIENTS WITH CEREBROVASCULAR DISEASE IN BELGIUM, GERMANY, SPAIN, UNITED KINGDOM, AND SWEDEN
Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)64903-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)64903-0/fulltext
Section Title :
Section Order :
60
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)64903-0&doi=10.1016/S1098-3015(10)64903-0